Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Korea's Health Ministry Gets In The Act To Generate Korean Innovation For U.S. Markets

This article was originally published in PharmAsia News

Executive Summary

SEOUL - South Korea's Ministry of Health and Welfare has selected 21 Korean pharmaceutical manufacturers and 17 medical equipment firms to support these companies in the development of globally competitive new drugs, marketing efforts and U.S. FDA approvals needed for their advancement into the U.S. market

You may also be interested in...

Korea’s Boryung Licenses Hypertension Therapy Kanarb To China’s Harbin Gloria

In its latest deal for the sale of its hypertension Kanarb product outside Korea, Boryung signed a 10-year deal with China from 2018.

Korea’s KHIDI Mobilizes Pharma Experts To Help Korean Pharma Go Global

KHIDI deploys pharma experts including former China FDA staffer to provide local Korean pharma with desperately needed advice for global regulatory submissions.

Hanmi Sees Double Again: Files For Combination Of Sanofi’s Aprovel And Pfizer’s Lipitor

A deal with Sanofi draws upon a 2009 co-marketing deal by Hanmi with Merck & Co. Inc. to pave the way.

Related Content




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts